mefloquine has been researched along with artemisinin in 124 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (10.48) | 18.7374 |
1990's | 25 (20.16) | 18.2507 |
2000's | 28 (22.58) | 29.6817 |
2010's | 52 (41.94) | 24.3611 |
2020's | 6 (4.84) | 2.80 |
Authors | Studies |
---|---|
Bogyo, M; Charman, SA; Fontaine, SD; Gut, J; Katneni, K; Lauterwasser, EM; Li, H; Renslo, AR; Rosenthal, PJ | 1 |
Albuquerque, IS; Burojević, J; D'Alessandro, S; Djurković-Djaković, O; Konstantinović, J; Machado, M; Pecic, S; Prudêncio, M; Sciotti, RJ; Šolaja, BA; Srbljanović, J; Štajner, T; Taramelli, D; Terzić, N; Tot, M; Verbić, T; Zlatović, M | 1 |
Feng, LS; Gao, C; Hu, YQ; Wu, X; Xu, L; Xu, Z; Zhang, S; Zhao, F | 1 |
Chu, XM; Gong, KK; Liang, LL; Liu, W; Sun, KL; Wang, C; Wang, WL | 1 |
Baum, J; Bridgford, JL; Charman, SA; Churchyard, A; Crespo, B; Deni, I; Fidock, DA; Gahalawat, S; Gamo, FJ; Laleu, B; Lawong, A; Mittal, N; Mok, S; Niederstrasser, H; Okombo, J; Palmer, MJ; Phillips, MA; Posner, B; Ready, JM; Striepen, J; Winzeler, E; Wittlin, S; Yeo, T; Zhou, A | 1 |
Augereau, JM; Benoit-Vical, F; Deraeve, C; Jimenez, T; Mustière, R; Nguyen, M; Ouji, M | 1 |
Chu, YH; Shao, BR; Ye, XY | 2 |
Than, M; Thwe, Y; Win, K | 1 |
Trigg, PI | 1 |
Bourdeau, EF; Childs, GE; Milhous, WK; Pang, L; Wimonwattratee, T | 1 |
Coulaud, JP; Ngo Van, P | 1 |
Newbold, CI; Pasvol, G; Peto, TE | 1 |
Arnold, K | 1 |
Walter, RD | 1 |
Druilhe, P; Gentilini, M; Stahel, E | 1 |
Coleman, RE; Do Rosario, VE; Hayes, DO; Hollingdale, MR; Vaughan, JA | 1 |
Wagner, WH | 1 |
Peters, W | 1 |
Li, GD | 1 |
Warhurst, DC | 1 |
Arnold, K; Guo, XB; Jiang, JB; Kong, YC; Li, GQ | 1 |
Arnold, K; Fu, LC; Guo, XB; Jian, HX; Li, GQ | 1 |
Chiodini, PL; Ellis, CJ | 1 |
Nosten, F; Price, RN | 1 |
Chen, PQ; Guo, XB; Li, GQ | 1 |
Baric, RS; Bright, P; Handy, J; Peel, SA; Yount, B | 1 |
Basco, LK; Le Bras, J | 2 |
Holfels, E; Mack, D; McAuley, J; McLeod, R; Milhous, WK | 1 |
Alin, MH; Ashton, M; Bjorkman, A; Bwijo, BA; Kihamia, CM; Mtey, GJ; Premji, Z | 1 |
Alin, MH; Ashton, M; Björkman, A; Kihamia, CM; Mtey, GJ | 1 |
Burgmann, H; Graninger, W; Looareesuwan, S; Vanijanonta, S; Viravan, C; Vorbach, H; Zedwitz-Liebenstein, K | 1 |
Heppner, DG; Kawamoto, F; Nguyen, TD; Sookto, P; Trieu, NT; Wimonwattrawatee, T; Wongsrichanalai, C | 1 |
Alin, MH | 1 |
Abbas, N; Alin, MH; Björkman, A; Bwijo, B; Wernsdorfer, W | 1 |
Arnold, K; Dung, NT; Hien, TT; HoaiTam, DT; Hung, NT; Mai, PP; Phung, MQ; Toan, LM; Vinh, NN; VinhChau, NV | 1 |
Kremsner, PG; Philipps, J; Radloff, PD; Wernsdorfer, W | 1 |
Le Bras, J | 1 |
Hien, TT; Nosten, F; White, NJ | 1 |
McIntosh, HM; Olliaro, P | 1 |
White, N | 1 |
Chongsuphajaisiddhi, T; Luxemburger, C; Nosten, F; Phaipun, L; Price, R; Simpson, JA; ter Kuile, F; van Vugt, M; White, NJ | 1 |
Duraisingh, MT; Jones, P; Pinder, M; Sambou, I; von Seidlein, L; Warhurst, DC | 2 |
Burgmann, H; Chullawichit, S; Daxböck, F; El-Menyawi, I; Graninger, W; Looareesuwan, S; Stoiser, B; Thalhammer, F | 1 |
Caruana, SR; Cowman, AF; Kirk, K; Reed, MB; Saliba, KJ | 1 |
Duraisingh, MT; Roper, C; Walliker, D; Warhurst, DC | 1 |
Bloland, PB; Ettling, M; Meek, S | 1 |
Faiz, MA; Kawamoto, F; Laoboonchai, A; Lin, K; Noedl, H; Pang, LW; Wimonwattrawatee, T; Wongsrichanalai, C | 1 |
Kollaritsch, H; Krudsood, S; Looareesuwan, S; Noedl, H; Viriyavejakul, P; Wernsdorfer, WH; Wiedermann, G; Wilairatana, P | 1 |
Björkman, A; Gupta, S; Thapar, MM; Wernsdorfer, WH | 1 |
Alin, H; Ashton, M; Bergqvist, Y; Karlsson, MO; Svensson, US | 1 |
Fidock, DA; Sidhu, AB; Verdier-Pinard, D | 1 |
Dagan, A; Flescher, E; Gatt, S; Gold, D; Pankova-Kholmyansky, I; Skutelsky, E; Zaslavsky, Z | 1 |
Brown, ML; Geyer, JA; Terrell, JC; Trotta, RF | 1 |
Egan, J; Hoppe, HC; Meredith, SA; van Schalkwyk, DA; Weber, BW; Wiehart, UI | 1 |
Majori, G | 1 |
Day, NP; Dondorp, AM; Farrar, JJ; Green, MD; Hien, TT; Johnson, A; Looareesuwan, S; Lynam, AJ; Mayxay, M; McGready, R; Newton, PN; Petit, A; Smithuis, FM; Van Damme, W; White, NJ; Yeung, S | 1 |
Adams, B; Elandalloussi, LM; Smith, PJ | 1 |
Fidock, DA; Sidhu, AB; Valderramos, SG | 1 |
Krishna, S; Woodrow, CJ | 1 |
Ashley, E; Aye, KZ; Barends, M; Htet, L; Kyaw, MK; Lindegardh, N; Lwin, S; Phe, O; Singtoroj, T; Smithuis, F; Stepniewska, K; White, NJ | 1 |
Fidock, DA; Krishna, S; Sidhu, AB; Uhlemann, AC; Valderramos, JC; Valderramos, SG | 1 |
Congpuong, K; Na-Bangchang, K | 1 |
Congpuong, K; Rojanawatsirivet, C; Sirichaisinthop, J; Wernsdorfer, G; Wernsdorfer, WH; Woitsch, B | 1 |
Mills, A; Socheat, D; Van Damme, W; White, NJ; Yeung, S | 1 |
Anova, L; Opsenica, DM; Smith, KS; Smith, PL; Solaja, BA; Terzić, N; Yang, Y | 1 |
Brittenham, GM; Kano, S; Krudsood, S; Li, G; Looareesuwan, S; Pengruksa, C; Phophak, N; Tangpukdee, N; Thanachartwet, V; Wilairatana, P | 1 |
Chen, X; Hergenrother, PJ; Liu, JO; Posner, GH; Rosenthal, AS; Shapiro, TA; West, DC | 1 |
Co, EM; Dennull, RA; Johnson, JD; Reinbold, DD; Waters, NC | 1 |
Donegan, S; Garner, P; Olliaro, P; Sinclair, D; Zani, B | 1 |
Chavchich, M; Chen, N; Cheng, Q; Gerena, L; Kyle, DE; Peters, J | 1 |
Alvarez, G; Blair, S; Piñeros, JG; Ríos, A; Tobón, A | 1 |
Alvarez, M; Benoit-Vical, F; Berry, A; Iriart, X; Magnaval, JF; Marchou, B; Menard, S; Naneix-Laroche, V; Soh, PN; Witkowski, B | 1 |
Duthaler, U; Keiser, J; Utzinger, J | 1 |
Björkman, A; Ferreira, PE; Gil, JP; Ribacke, U; Schmidt, BA; Tichopad, A; Veiga, MI | 1 |
Ashley, E; Aung, PP; Imwong, M; Kyaw, MK; Lee, SJ; Myint, NZ; Naing, AL; Nyo, MY; Oo, AP; Phe, O; Smithuis, F; White, NJ; Win, T | 1 |
Chen, N; Cheng, Q; Gatton, ML; Kyle, DE; Peters, J; Teuscher, F | 1 |
Congpuong, K; Kerschbaumer, G; Sirichaisinthop, J; Wernsdorfer, G; Wernsdorfer, WH; Wiedermann, U | 1 |
Congpuong, K; Hüttinger, F; Satimai, W; Wernsdorfer, G; Wernsdorfer, WH; Wiedermann, U | 1 |
Moon, DK; Parkin, S; Posner, GH; Siegler, MA; Sullivan, D; Tripathi, A | 1 |
Carvalho, LJ; Clemmer, L; Frangos, JA; Martins, YC; Zanini, GM | 1 |
Björkman, A; Ferreira, PE; Gil, JP; Jörnhagen, L; Kone, A; Malmberg, M; Nosten, F; Petzold, M; Schmidt, BA; Veiga, MI | 1 |
Borges, S; Cravo, P; Creasey, A; Fawcett, R; Hunt, P; Martinelli, A; Modrzynska, K; Rodrigues, L | 1 |
Congpuong, K; Sirichaisinthop, J; Treiber, M; Wernsdorfer, G; Wernsdorfer, WH; Wiedermann, U | 1 |
Ensom, MH; Wilby, KJ | 1 |
Kittikool, D; Sibmooh, N; Srihirun, S; Tangnitipong, S; Thaptimthong, T; Udomsangpetch, R; Unchern, S | 1 |
Arango, EM; Carmona-Fonseca, J; Upegui, YA | 1 |
Al-Farsi, HM; Al-Hashami, ZS; Al-Qahtani, A; Al-Sheikh, AA; Babiker, HA; Bin Dajem, SM | 1 |
Jacobine, AM; Mazzone, JR; Posner, GH; Slack, RD; Sullivan, DJ; Tripathi, AK | 1 |
Delacollette, C; Kaewkungwal, J; Khamsiriwatchara, A; Lawpoolsri, S; Potithavoranan, T; Sangvichean, A; Satimai, W; Sawang, S; Singhasivanon, P; Sudathip, P; Vijaykadga, S | 1 |
Amaratunga, C; Anderson, JM; Anderson, TJ; Dondorp, AM; Duong, S; Fairhurst, RM; Fay, MP; Jiang, H; Lim, P; Lindegardh, N; Mao, S; Mu, J; Phelps, ES; Song, J; Sreng, S; Stepniewska, K; Su, XZ; Suon, S; White, NJ; Zhou, C | 1 |
Garner, P; Gelband, H; Graves, PM | 3 |
Ariey, F; Beck, HP; Csajka, C; Decosterd, LA; Duong, S; Genton, B; Guidi, M; Kabanywanyi, AM; Olliaro, P; Staehli Hodel, EM | 1 |
Beeson, JG; Goodman, CD; Langer, C; McFadden, GI; Wilson, DW | 1 |
Ashley, E; Boel, M; Carrara, VI; Chu, C; Lwin, KM; McGready, R; Nosten, F; Phyo, AP; Proux, S; Rijken, M; Singhasivanon, P; Sriprawat, K; White, N; Wiladphaingern, J | 1 |
Alcantara, LM; Ayong, LS; Franco, CH; Franzoi, KD; Freitas-Junior, LH; Kim, J; Lee, S; Moraes, CB | 1 |
Cooksey, R; Dahlström, S; Fairhurst, RM; Flegg, JA; Guerin, PJ; Johnson, JD; Le Bras, J; Le Nagard, H; Lim, P; Ménard, D; Mentré, F; Murillo, C; Musset, L; Noedl, H; Nosten, F; Nsobya, SL; Pradines, B; Quashie, NB; Sibley, CH; Sinou, V; Sriprawat, K; Woodrow, CJ | 1 |
Dondorp, AM; Faiz, MA; Hien, TT; Mokuolu, OA; Pukrittayakamee, S; White, NJ | 1 |
Aubouy, A; Dahlström, S; Deloron, P; Ezinmègnon, S; Faucher, JF; Houzé, P; Houzé, S; Kendjo, E; Le Bras, J; Maïga-Ascofaré, O; Massougbodji, A; Wakpo, A | 1 |
Cremers, S; Fidock, DA; Henrich, PP; Kyle, DE; O'Brien, C; Sáenz, FE | 1 |
Conyers, RC; Mazzone, JR; Mott, BT; Posner, GH; Siegler, MA; Sullivan, DJ; Tripathi, AK | 1 |
Bukirwa, H; Kramer, CV; Nair, S; Sinclair, D; Tharyan, P; Unnikrishnan, B | 1 |
Dahlstrom, S; Ferreira, PE; Franzén, O; Gil, JP; Lum, JK; Nosten, F; Osório, NS; Veiga, MI | 1 |
Buathong, N; Chanarat, N; Chann, S; Chaorattanakawee, S; Chuor, CM; Gosi, P; Heng, TK; Jacob, C; Kong, N; Kuntawunginn, W; Lanteri, CA; Lin, JT; Lon, C; Plowe, C; Prom, S; Saingam, P; Saunders, DL; Se, Y; Sea, D; Sriwichai, S; Sundrakes, S; Takala-Harrison, S; Tangthongchaiwiriya, K; Teja-Isavadharm, P; Tyner, SD; Yingyuen, K; Yom, Y | 1 |
Bouth, DM; Char, MC; Domergue, A; Duru, V; Khim, N; Kim, S; Leang, R; Menard, D; Ringwald, P; Song, L; Tarning, J; Taylor, WR; Witkowski, B | 1 |
Akala, HM; Auschwitz, JM; Cheruiyot, AC; Gaona, HW; Hickman, MR; Johnson, JD; Kamau, E; Lee, PJ; Leed, SE; Murthy, T; Okello, CO; Talwar, M; Yeda, RA | 1 |
Bhardwaj, J; Goyal, M; Prakash, K; Puri, SK; Siddiqui, AJ; Soni, A | 1 |
Maxmen, A | 1 |
Cabral, L; Cristiano, ML; Lobo, L; Nogueira, F; Sousa, Bd | 1 |
Ackermann, I; Aubin, F; Carn, G; Gesase, S; Lusingu, JPA; Mnkande, E; Mrango, Z; Mtoro, A; Ngocho, JS; Ogutu, B; Onyango, KO; Ouedraogo, A; Sirima, SB; Strub, N; Vanraes, J; Yaro, JB | 1 |
Liu, XJ; Peng, HJ; Wei, HX; Xia, J; Zhou, LJ | 1 |
Bailey, JA; Barnett, EJ; Brazeau, NF; Chaorattanakawee, S; Gosi, P; Juliano, JJ; Lanteri, CA; Lin, JT; Lon, C; Meshnick, SR; Norris, LD; Parobek, CM; Parr, JB; Saunders, DL; Spring, MD | 1 |
Chaijaroenkul, W; Na-Bangchang, K; Phompradit, P | 1 |
Cao, P; Dini, S; Fowkes, FJI; McCaw, JM; Price, RN; Simpson, JA; van der Pluijm, RW; Zaloumis, S | 1 |
Buffet, P; Chambrion, C; Chartrel, N; Mouri, O; Ndour, PA; Roussel, C; Smith, B; Smith, P; Thellier, M; Wojnarski, M | 1 |
Chy, S; Felger, I; Hastings, I; Hodel, EM; Jones, S; Kay, K; Mbituyumuremyi, A; Menard, D; Uwimana, A | 1 |
Amaratunga, C; Amato, R; Anvikar, AR; Ashley, E; Baidya, S; Behera, PK; Callery, JJ; Chau, NH; Cheah, PY; Chotivanich, K; Chutasmit, K; Day, NPJ; Dhorda, M; Dondorp, AM; Fairhurst, RM; Faiz, A; Fanello, C; Gantait, K; Ghosh, T; Gonçalves, S; Grobusch, MP; Hanboonkunupakarn, B; Heaton, J; Hien, TT; Hlaing, TM; Hoa, NT; Hoglund, RM; Huy, R; Imwong, M; Jacob, CG; Jittamala, P; Kaewmok, W; Kwiatkowski, DP; Lek, D; Lin, K; Mao, S; Maude, RJ; Mayxay, M; Miotto, O; Mohanty, AK; Mukaka, M; Newton, PN; Onyamboko, M; Oun, S; Pearson, RD; Peto, TJ; Pukrittayakamee, S; Pyae Phyo, A; Runcharern, R; Saelow, C; Satpathi, P; Satpathi, S; Smithuis, F; Sovann, Y; Sreng, S; Suon, S; Tarning, J; Thanh, NV; Thant, M; Thuy-Nhien, NT; Tripura, A; Tripura, R; Ul Islam, A; Valecha, N; van der Pluijm, RW; van Vugt, M; von Seidlein, L; Waithira, N; White, NJ; Winterberg, M; Woodrow, CJ; Yen, S | 1 |
Anywar, DA; Auma, MA; Balikagala, B; Emoto, S; Fukuda, N; Hashimoto, M; Hirai, M; Horii, T; Ikeda, M; Kataoka, M; Katuro, OT; Kimura, E; Mita, T; Mori, T; Obwoya, PS; Odongo-Aginya, EI; Ogwang, M; Opio, W; Palacpac, NMQ; Sakurai-Yatsushiro, M; Sekihara, M; Tachibana, SI; Yamauchi, M; Yatsushiro, S | 1 |
Barale, JC; Bouillon, A; Chy, S; Eam, R; Kauy, C; Ke, S; Khean, C; Khim, N; Kim, S; Kloeung, N; Kul, C; Leang, R; Mairet-Khedim, M; Ringwald, P; Roesch, C; Srun, S; Witkowski, B | 1 |
Chiheb, D; Erhart, A; Guetens, P; Hong, NV; Imamura, H; Kattenberg, JH; Monsieurs, P; Phuc, BQ; Rosanas-Urgell, A; Rovira-Vallbona, E; Xa, NX | 1 |
21 review(s) available for mefloquine and artemisinin
Article | Year |
---|---|
Quinoline hybrids and their antiplasmodial and antimalarial activities.
Topics: Antimalarials; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines | 2017 |
Triazole derivatives and their antiplasmodial and antimalarial activities.
Topics: Animals; Antimalarials; Humans; Parasitic Sensitivity Tests; Plasmodium; Triazoles | 2019 |
The problem of drug resistance in malaria.
Topics: Africa; Animals; Antimalarials; Artemisinins; Chemical Phenomena; Chemistry; Chloroquine; Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Humans; India; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Sesquiterpenes; Sulfadoxine | 1985 |
New drugs and their potential use against drug-resistant malaria.
Topics: Aminoquinolines; Animals; Antimalarials; Artemisinins; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Mice; Naphthoquinones; Plasmodium falciparum; Pyrimethamine; Quinolines; Sesquiterpenes; Sulfadoxine | 1985 |
New antimalarials. A risk-benefit analysis.
Topics: Animals; Antimalarials; Artemisinins; Dose-Response Relationship, Drug; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum; Pregnancy; Risk Assessment; Sesquiterpenes | 1995 |
Management of multiple drug-resistant malaria in Viet Nam.
Topics: Antimalarials; Artemisinins; Clinical Trials as Topic; Drug Resistance, Multiple; Humans; Malaria; Mefloquine; Sesquiterpenes; Vietnam | 1997 |
Use of artemisinin derivatives for the control of malaria.
Topics: Antimalarials; Artemisinins; Drug Resistance; Drug Therapy, Combination; Humans; Incidence; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Prospective Studies; Refugees; Risk Factors; Seasons; Sesquiterpenes; Thailand; Treatment Outcome; Vietnam | 1998 |
Treatment of uncomplicated malaria with artemisinin derivatives. A systematic review of randomised controlled trials.
Topics: Adult; Antimalarials; Artemisinins; Child; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Randomized Controlled Trials as Topic; Research Design; Sesquiterpenes; Time Factors; Treatment Outcome | 1998 |
Combination therapy for malaria in Africa: hype or hope?
Topics: Africa; Antimalarials; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Cross-Cultural Comparison; Half-Life; Humans; Insecticide Resistance; Malaria; Mefloquine; Pyrimethamine; Self Medication; Sesquiterpenes; Sulfadoxine; Thailand | 2000 |
[Combined antimalarial therapy using artemisinin].
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Doxycycline; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Plasmodium; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2004 |
Antimalarial drugs: recent advances in molecular determinants of resistance and their clinical significance.
Topics: Africa; Amino Alcohols; Animals; Antimalarials; Artemisinins; Asia, Southeastern; Biological Transport; Calcium-Transporting ATPases; Chloroquine; Drug Resistance; Drug Resistance, Multiple; Drug Therapy, Combination; Gene Amplification; Humans; Malaria, Falciparum; Mefloquine; Membrane Proteins; Membrane Transport Proteins; Models, Biological; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Quinine; Sesquiterpenes | 2006 |
Current malaria status and distribution of drug resistance in East and Southeast Asia with special focus to Thailand.
Topics: Age Factors; Animals; Antimalarials; Artemisinins; Asia, Southeastern; Chloroquine; Drug Resistance; Humans; Malaria; Mefloquine; Plasmodium; Quinine; Sesquiterpenes; Sex Factors; Sulfadoxine | 2007 |
Artemisinin-based combination therapy for treating uncomplicated malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Sulfadoxine | 2009 |
Update on the diagnosis and treatment of food-borne trematode infections.
Topics: Animals; Anthelmintics; Artemisinins; Benzimidazoles; Foodborne Diseases; Humans; Immunoassay; Mefloquine; Molecular Diagnostic Techniques; Phenylenediamines; Praziquantel; Sensitivity and Specificity; Trematode Infections; Triclabendazole | 2010 |
Pharmacokinetics of antimalarials in pregnancy: a systematic review.
Topics: Anti-Bacterial Agents; Antimalarials; Artemisinins; Atovaquone; Chloroquine; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Proguanil; Pyrimethamine; Quinine; Sulfadoxine | 2011 |
Primaquine for reducing Plasmodium falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2012 |
Malaria.
Topics: Africa South of the Sahara; Amodiaquine; Animals; Anopheles; Antimalarials; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Insecticide-Treated Bednets; Insecticides; Malaria; Malaria Vaccines; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Pregnancy; Pregnancy Complications, Infectious; Primary Prevention; Pyrimethamine; Quinine; Quinolines; Seasons; Sulfadoxine | 2014 |
Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Child; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Liver; Lumefantrine; Malaria, Falciparum; Mefloquine; Naphthyridines; Randomized Controlled Trials as Topic | 2014 |
Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2014 |
Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2015 |
Risk of drug resistance in Plasmodium falciparum malaria therapy-a systematic review and meta-analysis.
Topics: Amodiaquine; Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Risk; Sulfadoxine | 2017 |
17 trial(s) available for mefloquine and artemisinin
Article | Year |
---|---|
Comparison of combinations of parenteral artemisinin derivatives plus oral mefloquine with intravenous quinine plus oral tetracycline for treating cerebral malaria.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Humans; Malaria, Cerebral; Mefloquine; Middle Aged; Prospective Studies; Quinine; Sesquiterpenes; Tetracycline | 1992 |
The problem of drug resistance in malaria.
Topics: Africa; Animals; Antimalarials; Artemisinins; Chemical Phenomena; Chemistry; Chloroquine; Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Humans; India; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Sesquiterpenes; Sulfadoxine | 1985 |
Antimalarial activity of mefloquine and qinghaosu.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemisinins; Child; China; Female; Humans; Injections, Intramuscular; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Quinolines; Sesquiterpenes; Time Factors | 1982 |
Randomised comparative study of mefloquine, qinghaosu, and pyrimethamine-sulfadoxine in patients with falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; China; Clinical Trials as Topic; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Quinolines; Random Allocation; Sesquiterpenes; Sulfadoxine; Sulfanilamides | 1984 |
[The infectivity of gametocytes of Plasmodium falciparum from patients treated with artemisinine].
Topics: Animals; Anopheles; Antimalarials; Artemisinins; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Sesquiterpenes | 1994 |
Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drugs, Chinese Herbal; Erythrocytes; Humans; Injections, Intravenous; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Plasmodium falciparum; Recurrence; Sesquiterpenes; Tanzania | 1995 |
Clinical efficacy and pharmacokinetics of artemisinin monotherapy and in combination with mefloquine in patients with falciparum malaria.
Topics: Administration, Oral; Adult; Animals; Antimalarials; Artemisinins; Drug Therapy, Combination; Female; Half-Life; Humans; Malaria, Falciparum; Male; Mefloquine; Sesquiterpenes | 1996 |
In vivo-in vitro model for the assessment of clinically relevant antimalarial cross-resistance.
Topics: Adult; Animals; Antimalarials; Artemisinins; Chloroquine; Cross Reactions; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Models, Biological; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinine; Recurrence; Sesquiterpenes | 2001 |
Population pharmacokinetic and pharmacodynamic modelling of artemisinin and mefloquine enantiomers in patients with falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Drug Interactions; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Middle Aged; Models, Biological; Sesquiterpenes; Stereoisomerism; Structure-Activity Relationship | 2002 |
Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
Topics: Adolescent; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Myanmar; Plasmodium falciparum; Quinolines; Recurrence; Sesquiterpenes; Treatment Outcome | 2006 |
Efficacy of Artequick versus artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Primaquine; Prospective Studies; Quinolines; Thailand; Treatment Outcome | 2008 |
Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Myanmar; Plasmodium falciparum; Primaquine; Treatment Outcome; Young Adult | 2010 |
Efficacy of different primaquine-based antimalarial regimens against Plasmodium falciparum gametocytemia.
Topics: Adolescent; Adult; Aged; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Colombia; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Germ Cells; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Plasmodium falciparum; Primaquine; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2012 |
Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Cambodia; Drug Resistance; Female; Genotype; Glucosephosphate Dehydrogenase; Humans; Malaria, Falciparum; Male; Mefloquine; Microsatellite Repeats; Plasmodium falciparum; Treatment Outcome; Young Adult | 2012 |
Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment.
Topics: Adolescent; Adult; Antigens, Bacterial; Antigens, Surface; Antimalarials; Artemisinins; Cambodia; Child; Child, Preschool; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Quinolines; Treatment Failure; Young Adult | 2015 |
Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial.
Topics: Africa South of the Sahara; Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Patient Safety; Polymerase Chain Reaction | 2016 |
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.
Topics: Adolescent; Adult; Amodiaquine; Anthraquinones; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Polymerase Chain Reaction; Quinolines; Treatment Outcome; Young Adult | 2020 |
87 other study(ies) available for mefloquine and artemisinin
Article | Year |
---|---|
Trioxolane-Mediated Delivery of Mefloquine Limits Brain Exposure in a Mouse Model of Malaria.
Topics: | 2015 |
Reinvestigating Old Pharmacophores: Are 4-Aminoquinolines and Tetraoxanes Potential Two-Stage Antimalarials?
Topics: Aminoquinolines; Animals; Antimalarials; Drug Evaluation, Preclinical; Ether-A-Go-Go Potassium Channels; Hemin; Hepatocytes; Humans; In Vitro Techniques; Liver; Mice; Microsomes, Liver; Parasite Load; Plasmodium berghei; Plasmodium falciparum; Structure-Activity Relationship; Tetraoxanes | 2016 |
Novel Antimalarial Tetrazoles and Amides Active against the Hemoglobin Degradation Pathway in
Topics: Amides; Antimalarials; Drug Resistance, Microbial; Hemeproteins; Hemoglobins; Hep G2 Cells; Humans; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Small Molecule Libraries; Structure-Activity Relationship; Tetrazoles | 2021 |
Novel molecule combinations and corresponding hybrids targeting artemisinin-resistant Plasmodium falciparum parasites.
Topics: Antimalarials; Artemisinins; Atovaquone; Dose-Response Relationship, Drug; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship; Triclosan | 2021 |
[The blood schizontocidal effects of pyronaridine, amodiaquine, mefloquine and qinghaosu on mice infected with Plasmodium berghei].
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Drug Resistance; Female; Malaria; Male; Mefloquine; Mice; Naphthyridines; Plasmodium berghei; Sesquiterpenes | 1992 |
Comparison of effects of pyronaridine, amodiaquine, mefloquine and qinghaosu on rodent malaria.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Resistance; Female; Malaria; Male; Mefloquine; Mice; Naphthyridines; Plasmodium berghei; Sesquiterpenes | 1992 |
Drug use and design in the nineties.
Topics: Aminoquinolines; Amodiaquine; Antimalarials; Artemisinins; Calcium Channel Blockers; Chloroquine; Humans; Malaria; Mefloquine; Naphthoquinones; Phenanthrenes; Primaquine; Quinine; Sesquiterpenes; Sulfadoxine | 1991 |
In vitro and clinical correlates of mefloquine resistance of Plasmodium falciparum in eastern Thailand.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Butylated Hydroxytoluene; Chloroquine; Drug Resistance; Drugs, Chinese Herbal; Mefloquine; Molecular Structure; Phenanthrenes; Plasmodium falciparum; Pyridines; Pyrimethamine; Quinine; Sesquiterpenes; Thailand | 1991 |
[New antiparasitic drugs].
Topics: Amebicides; Anthelmintics; Antifungal Agents; Antimalarials; Artemisinins; Fluconazole; Humans; Itraconazole; Ketoconazole; Mefloquine; Phenanthrenes; Quinolines; Sesquiterpenes; Triazoles | 1988 |
Qinghaosu, mefloquine, and pyrimethamine-sulfadoxine in falciparum malaria.
Topics: Antimalarials; Artemisinins; Drug Combinations; Humans; Malaria; Mefloquine; Pyrimethamine; Quinolines; Sesquiterpenes; Sulfadoxine | 1985 |
Qinghaosu, mefloquine, and pyrimethamine-sulfadoxine in falciparum malaria.
Topics: Artemisinins; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Pyrimethamine; Quinolines; Sesquiterpenes; Sulfadoxine; Sulfanilamides | 1985 |
Plasmodium falciparum: inhibition of dolichol kinase by mefloquine.
Topics: Animals; Artemisinins; Cations, Divalent; Chloroquine; Cytidine Triphosphate; Detergents; Dolichols; Egtazic Acid; Erythrocytes; Hydrogen-Ion Concentration; Kinetics; Mefloquine; Microsomes; Nucleotides; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor); Plasmodium falciparum; Quinolines; Sesquiterpenes; Trifluoperazine | 1986 |
Antagonism of chloroquine with other antimalarials.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Interactions; Drug Resistance; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Sesquiterpenes; Sulfadoxine | 1988 |
Effect of mefloquine and artemisinin on the sporogonic cycle of Plasmodium berghei ANKA in Anopheles stephensi mosquitoes.
Topics: Animals; Anopheles; Antimalarials; Artemisinins; Female; Insect Vectors; Malaria; Mefloquine; Mice; Plasmodium berghei; Quinolines; Sesquiterpenes | 1988 |
[Control of malaria--chemotherapy and immunoprophylaxis. 1. Chemotherapy].
Topics: Antimalarials; Artemisinins; Drug Combinations; Drug Resistance; Humans; In Vitro Techniques; Malaria; Mefloquine; Plasmodium; Quinolines; Sesquiterpenes; Vaccination | 1986 |
[Development of a piperaquine-resistant line of Plasmodium berghei K 173 strain].
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Resistance; Malaria; Male; Mefloquine; Mice; Plasmodium berghei; Quinolines; Sesquiterpenes | 1985 |
The treatment of falciparum malaria.
Topics: Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Humans; Malaria; Mefloquine; Plasmodium falciparum; Quinidine; Quinine; Quinolines; Sesquiterpenes | 1984 |
A strong association between mefloquine and halofantrine resistance and amplification, overexpression, and mutation in the P-glycoprotein gene homolog (pfmdr) of Plasmodium falciparum in vitro.
Topics: Animals; Antimalarials; Artemisinins; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Blotting, Northern; Blotting, Southern; Chloroquine; DNA Primers; DNA, Protozoan; Drug Resistance; Gene Amplification; Gene Expression; Genes, Protozoan; Mefloquine; Molecular Sequence Data; Phenanthrenes; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Quinine; RNA, Messenger; Selection, Genetic; Sequence Homology, Nucleic Acid; Sesquiterpenes | 1994 |
In vitro susceptibility of Cambodian isolates of Plasmodium falciparum to halofantrine, pyronaridine and artemisinin derivatives.
Topics: Adult; Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Humans; In Vitro Techniques; Mefloquine; Naphthyridines; Phenanthrenes; Plasmodium falciparum; Proguanil; Pyrimethamine; Quinine; Sesquiterpenes; Triazines | 1994 |
In vitro effects of artemisinin ether, cycloguanil hydrochloride (alone and in combination with sulfadiazine), quinine sulfate, mefloquine, primaquine phosphate, trifluoperazine hydrochloride, and verapamil on Toxoplasma gondii.
Topics: Animals; Artemisinins; Female; Mefloquine; Mice; Primaquine; Proguanil; Quinine; Sesquiterpenes; Sulfadiazine; Toxoplasma; Triazines; Trifluoperazine; Uracil; Verapamil | 1994 |
In vitro activity of artemisinin derivatives against African isolates and clones of Plasmodium falciparum.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Drug Resistance; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine; Sesquiterpenes | 1993 |
Serum laminin and basic fibroblast growth factor concentrations in patients with complicated Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Fibroblast Growth Factor 2; Humans; Kinetics; Laminin; Malaria, Falciparum; Mefloquine; Middle Aged; Sesquiterpenes | 1996 |
In vitro susceptibility of Plasmodium falciparum isolates in Vietnam to artemisinin derivatives and other antimalarials.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Mefloquine; Microbial Sensitivity Tests; Plasmodium falciparum; Quinine; Sesquiterpenes; Vietnam | 1997 |
In vitro susceptibility of Tanzanian wild isolates of Plasmodium falciparum to artemisinin, chloroquine, sulfadoxine/pyrimethamine and mefloquine.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Humans; Mefloquine; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Tanzania | 1997 |
Efficacy of artemisinin and mefloquine combinations against Plasmodium falciparum. In vitro simulation of in vivo pharmacokinetics.
Topics: Animals; Antimalarials; Artemisinins; Drug Synergism; Mefloquine; Plasmodium falciparum; Sesquiterpenes | 1997 |
Follow-up of the susceptibility of Plasmodium falciparum to antimalarials in Gabon.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Dose-Response Relationship, Drug; Drug Resistance; Follow-Up Studies; Gabon; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine; Sesquiterpenes; Sulfadoxine | 1998 |
In vitro susceptibility of African Plasmodium falciparum isolates to dihydroartemisinin and the risk factors for resistance to qinghaosu.
Topics: Africa; Animals; Antimalarials; Artemisinins; Chloroquine; Cross Reactions; Drug Evaluation, Preclinical; Drug Resistance; France; Humans; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum; Sesquiterpenes; Travel | 1998 |
Antimalarial drug resistance and combination chemotherapy.
Topics: Animals; Antimalarials; Artemisinins; Atovaquone; Chloroquine; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Naphthoquinones; Plasmodium falciparum; Sesquiterpenes | 1999 |
Risk factors for gametocyte carriage in uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Carrier State; Child; Child, Preschool; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Multivariate Analysis; Parasitemia; Phenanthrenes; Plasmodium falciparum; Prospective Studies; Quinine; Regression Analysis; Risk Factors; Seroepidemiologic Studies; Sesquiterpenes; Thailand | 1999 |
Inoculum effect leads to overestimation of in vitro resistance for artemisinin derivatives and standard antimalarials: a Gambian field study.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Gambia; Hematocrit; Humans; Malaria, Falciparum; Mefloquine; Parasitemia; Phenanthrenes; Plasmodium falciparum; Quinine; Scintillation Counting; Sensitivity and Specificity; Sesquiterpenes | 1999 |
Serum concentrations of granulocyte-colony stimulating factor in complicated Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Calcitonin; Calcitonin Gene-Related Peptide; Chemokine CCL4; Child; Enzyme-Linked Immunosorbent Assay; Erythrocytes; Erythropoietin; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Macrophage Inflammatory Proteins; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Nitrates; Plasmodium falciparum; Protein Precursors; Reference Values; Sesquiterpenes; Stem Cell Factor | 2000 |
Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum.
Topics: Amino Acid Substitution; Animals; Antimalarials; Artemisinins; ATP-Binding Cassette Transporters; Chloroquine; Cloning, Molecular; Drug Resistance; Mefloquine; Mutation; Phenanthrenes; Plasmodium falciparum; Protozoan Proteins; Quinine; Sesquiterpenes; Verapamil | 2000 |
The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin.
Topics: Alleles; Animals; Antimalarials; Artemisinins; ATP-Binding Cassette Transporters; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Protozoan Proteins; Sesquiterpenes; Tetrahydrofolate Dehydrogenase; Tyrosine | 2000 |
Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum.
Topics: Animals; Antimalarials; Artemisinins; ATP-Binding Cassette Transporters; Cells, Cultured; Humans; Mefloquine; Mutagenesis; Plasmodium falciparum; Protozoan Proteins; Sesquiterpenes | 2000 |
In vitro susceptibility of Plasmodium falciparum isolates from Myanmar to antimalarial drugs.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Sesquiterpenes | 2001 |
In vitro interactions of artemisinin with atovaquone, quinine, and mefloquine against Plasmodium falciparum.
Topics: Animals; Antimalarials; Artemisinins; Atovaquone; Drug Synergism; Humans; Mefloquine; Naphthoquinones; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinine; Sesquiterpenes | 2002 |
Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations.
Topics: Alleles; Amodiaquine; Animals; Antimalarials; Artemisinins; ATP-Binding Cassette Transporters; Chloroquine; Cloning, Molecular; Drug Resistance; Genes, Protozoan; Haplotypes; Mefloquine; Membrane Proteins; Membrane Transport Proteins; Parasitic Sensitivity Tests; Phenotype; Plasmodium falciparum; Point Mutation; Protozoan Proteins; Quinine; Sesquiterpenes; Transfection; Verapamil | 2002 |
Ceramide mediates growth inhibition of the Plasmodium falciparum parasite.
Topics: Animals; Antiprotozoal Agents; Apoptosis; Artemisinins; Ceramides; Glutathione; Growth Inhibitors; Lysophospholipids; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Sesquiterpenes; Sphingomyelin Phosphodiesterase; Sphingosine | 2003 |
Defective DNA repair as a potential mechanism for the rapid development of drug resistance in Plasmodium falciparum.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; DNA Damage; DNA Repair; Drug Resistance; Drug Resistance, Multiple; Humans; Malaria, Falciparum; Mefloquine; Parasitic Sensitivity Tests; Phenanthrenes; Plasmodium falciparum; Pyrimethamine; Quinine; Sesquiterpenes; Sulfanilamide; Sulfanilamides; Ultraviolet Rays | 2004 |
Antimalarial quinolines and artemisinin inhibit endocytosis in Plasmodium falciparum.
Topics: Ammonium Chloride; Animals; Antimalarials; Artemisinins; Biotin; Blotting, Western; Chloroquine; Dextrans; Endocytosis; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique; Fluorescent Dyes; Hemoglobins; Mefloquine; Microscopy, Electron; Microscopy, Fluorescence; Monensin; Plasmodium falciparum; Quinolones; Sesquiterpenes; Transport Vesicles; Vacuoles | 2004 |
Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials.
Topics: Antimalarials; Artemisinins; Artesunate; Asia, Southeastern; Cross-Sectional Studies; Drug Labeling; Fraud; Humans; Malaria; Mefloquine; Self Medication; Sesquiterpenes | 2004 |
ATPase activity of purified plasma membranes and digestive vacuoles from Plasmodium falciparum.
Topics: Adenosine Triphosphatases; Animals; Antimalarials; Artemisinins; Cell Membrane; Chloroquine; Drug Resistance; Mefloquine; Plasmodium falciparum; Quinine; Sesquiterpenes; Subcellular Fractions; Vacuoles | 2005 |
pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum.
Topics: Alleles; Animals; Antimalarials; Artemisinins; Asparagine; Aspartic Acid; ATP-Binding Cassette Transporters; Drug Resistance; Mefloquine; Phenanthrenes; Plasmodium falciparum; Point Mutation; Protozoan Proteins; Quinine; Sesquiterpenes | 2005 |
Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin.
Topics: Animals; Antimalarials; Artemisinins; ATP-Binding Cassette Transporters; DNA, Protozoan; Drug Resistance, Multiple; Ethanolamines; Fluorenes; Genes, MDR; Inhibitory Concentration 50; Lumefantrine; Malaria, Falciparum; Mefloquine; Parasitic Sensitivity Tests; Phenanthrenes; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Quinine; Sesquiterpenes | 2006 |
Susceptibility to chloroquine, mefloquine and artemisinin of Plasmodium vivax in northwestern Thailand.
Topics: Antimalarials; Artemisinins; Chloroquine; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Humans; Lethal Dose 50; Malaria, Vivax; Mefloquine; Plasmodium vivax; Survival Rate; Thailand; Treatment Outcome | 2007 |
Cost of increasing access to artemisinin combination therapy: the Cambodian experience.
Topics: Animals; Antimalarials; Artemisinins; Cambodia; Costs and Cost Analysis; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine | 2008 |
Mixed tetraoxanes containing the acetone subunit as antimalarials.
Topics: Acetone; Animals; Antimalarials; Artemisinins; Drug Evaluation, Preclinical; Drug Resistance, Multiple; Mefloquine; Mice; Plasmodium falciparum; Tetraoxanes | 2008 |
Malaria-infected mice are cured by a single oral dose of new dimeric trioxane sulfones which are also selectively and powerfully cytotoxic to cancer cells.
Topics: Administration, Oral; Animals; Antimalarials; Antineoplastic Agents; Artemisinins; Cell Line, Tumor; Drug Screening Assays, Antitumor; Drug Stability; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Mice; Sulfones | 2009 |
Assessment of malaria in vitro drug combination screening and mixed-strain infections using the malaria Sybr green I-based fluorescence assay.
Topics: Animals; Antimalarials; Artemisinins; Benzothiazoles; Chloroquine; Diamines; Drug Combinations; Drug Evaluation, Preclinical; Drug Interactions; Fluorescent Dyes; Hypoxanthine; Mefloquine; Organic Chemicals; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines | 2009 |
Role of pfmdr1 amplification and expression in induction of resistance to artemisinin derivatives in Plasmodium falciparum.
Topics: Alleles; Animals; Antimalarials; Artemisinins; Drug Resistance; Gene Amplification; Gene Dosage; Gene Expression; Genes, Protozoan; Humans; In Vitro Techniques; Malaria, Falciparum; Mefloquine; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; RNA, Messenger; RNA, Protozoan | 2010 |
Dynamics of Plasmodium falciparum parasitemia regarding combined treatment regimens for acute uncomplicated malaria, Antioquia, Colombia.
Topics: Administration, Oral; Animals; Antimalarials; Artemisinins; Artesunate; Clinical Protocols; Colombia; Drug Therapy, Combination; Female; Humans; Malaria; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Patient Compliance; Plasmodium falciparum; Primaquine; Treatment Outcome | 2010 |
pfmdr1 amplification associated with clinical resistance to mefloquine in West Africa: implications for efficacy of artemisinin combination therapies.
Topics: Adult; Africa, Western; Artemisinins; Drug Resistance; Drug Therapy, Combination; Gene Dosage; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Male; Mefloquine; Multidrug Resistance-Associated Proteins; Treatment Failure | 2010 |
Antimalarial exposure delays Plasmodium falciparum intra-erythrocytic cycle and drives drug transporter genes expression.
Topics: Antimalarials; Artemisinins; Cell Cycle; Drug Therapy, Combination; Erythrocytes; Gene Expression Regulation; Mefloquine; Membrane Transport Proteins; Plasmodium falciparum; Protozoan Proteins; RNA, Messenger | 2010 |
Artemisinin‐induced dormancy in plasmodium falciparum: duration, recovery rates, and implications in treatment failure.
Topics: Antimalarials; Artemisinins; Mefloquine; Microbial Viability; Plasmodium falciparum; Time Factors | 2010 |
Synergism between mefloquine and artemisinin and its enhancement by retinol in Plasmodium falciparum in vitro.
Topics: Antimalarials; Artemisinins; Dose-Response Relationship, Drug; Drug Synergism; Lethal Dose 50; Mefloquine; Plasmodium falciparum; Thailand; Vitamin A | 2010 |
Sensitivity to artemisinin, mefloquine and quinine of Plasmodium falciparum in northwestern Thailand.
Topics: Antimalarials; Artemisinins; Dose-Response Relationship, Drug; Lethal Dose 50; Mefloquine; Plasmodium falciparum; Quinine; Thailand | 2010 |
A single, low, oral dose of a 5-carbon-linked trioxane dimer orthoester plus mefloquine cures malaria-infected mice.
Topics: Administration, Oral; Animals; Antimalarials; Artemisinins; Crystallography, X-Ray; Drug Therapy, Combination; Esters; Heterocyclic Compounds; Heterocyclic Compounds, 4 or More Rings; Malaria; Mefloquine; Mice; Molecular Structure; Plasmodium berghei | 2011 |
Artemether and artesunate show the highest efficacies in rescuing mice with late-stage cerebral malaria and rapidly decrease leukocyte accumulation in the brain.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Brain; Leukocytes; Malaria, Cerebral; Mefloquine; Mice; Parasitemia; Plasmodium berghei; Quinine | 2011 |
Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance.
Topics: Animals; Antimalarials; Artemisinins; ATP-Binding Cassette Transporters; Base Sequence; Drug Resistance; Ethanolamines; Fluorenes; Gene Frequency; Genotype; Haplotypes; Humans; Inhibitory Concentration 50; Lumefantrine; Malaria, Falciparum; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins | 2011 |
Genomewide scan reveals amplification of mdr1 as a common denominator of resistance to mefloquine, lumefantrine, and artemisinin in Plasmodium chabaudi malaria parasites.
Topics: Antimalarials; Artemisinins; Base Sequence; Chromosome Mapping; Drug Resistance, Multiple; Ethanolamines; Fluorenes; Genetic Linkage; Genome, Protozoan; Lumefantrine; Malaria; Mefloquine; Multidrug Resistance-Associated Proteins; Plasmodium chabaudi; Sequence Analysis, DNA | 2011 |
Sensitivity of Plasmodium vivax to chloroquine, mefloquine, artemisinin and atovaquone in north-western Thailand.
Topics: Animals; Antimalarials; Artemisinins; Atovaquone; Chloroquine; Dose-Response Relationship, Drug; Lethal Dose 50; Mefloquine; Plasmodium vivax; Thailand | 2011 |
Extracellular heme enhances the antimalarial activity of artemisinin.
Topics: Antimalarials; Antioxidants; Artemisia; Artemisinins; Chloroquine; Cholesterol, LDL; Fluorescence; Heme; Hemin; Humans; Lipid Peroxidation; Mefloquine; Oxidants; Oxidation-Reduction; Plasmodium falciparum; Quinine; Tryptophan; Vitamin E | 2012 |
Distribution of drug resistance genotypes in Plasmodium falciparum in an area of limited parasite diversity in Saudi Arabia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant; Male; Mefloquine; Membrane Transport Proteins; Middle Aged; Multidrug Resistance-Associated Proteins; Mutation; Phenanthrenes; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Saudi Arabia; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2012 |
Malaria-infected mice live until at least day 30 after a new artemisinin-derived thioacetal thiocarbonate combined with mefloquine are administered together in a single, low, oral dose.
Topics: Acetals; Administration, Oral; Animals; Antimalarials; Artemisinins; Magnetic Resonance Spectroscopy; Malaria; Mefloquine; Mice; Mice, Inbred C57BL; Spectrometry, Mass, Fast Atom Bombardment | 2012 |
Artemisinin resistance containment project in Thailand. II: Responses to mefloquine-artesunate combination therapy among falciparum malaria patients in provinces bordering Cambodia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Epidemiological Monitoring; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Thailand; Treatment Outcome; Young Adult | 2012 |
Effect of single nucleotide polymorphisms in cytochrome P450 isoenzyme and N-acetyltransferase 2 genes on the metabolism of artemisinin-based combination therapies in malaria patients from Cambodia and Tanzania.
Topics: Alleles; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Arylamine N-Acetyltransferase; Base Sequence; Cambodia; Cytochrome P-450 Enzyme System; Drug Combinations; Ethanolamines; Fluorenes; Gene Frequency; Humans; Isoenzymes; Malaria; Mefloquine; Pharmacogenetics; Polymorphism, Single Nucleotide; Quinolines; Sequence Analysis, DNA; Tanzania | 2013 |
Defining the timing of action of antimalarial drugs against Plasmodium falciparum.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Chloroquine; Erythrocytes; Flow Cytometry; High-Throughput Screening Assays; Hydroxamic Acids; Inhibitory Concentration 50; Mefloquine; Merozoites; Plasmodium falciparum; Quinine; Quinolines; Schizonts; Time Factors | 2013 |
Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational study.
Topics: Antimalarials; Artemisinins; Artesunate; Climate; Community Health Workers; Cross-Sectional Studies; Drug Resistance; Female; Geography; Hospitalization; Humans; Malaria; Mefloquine; Myanmar; Plasmodium falciparum; Plasmodium vivax; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Rain; Reproducibility of Results; Temperature; Thailand; Transients and Migrants | 2013 |
Chemosensitization potential of P-glycoprotein inhibitors in malaria parasites.
Topics: Antimalarials; Artemisinins; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Boron Compounds; Chloroquine; Chlorpheniramine; Dibenzocycloheptenes; Drug Interactions; Drug Resistance, Multiple; Erythrocytes; Fluorescent Dyes; Gefitinib; Humans; Imatinib Mesylate; Mefloquine; Piperazines; Plasmodium falciparum; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; Quinolines | 2013 |
High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool.
Topics: Amodiaquine; Antimalarials; Artemisinins; Automation, Laboratory; Chloroquine; Drug Resistance; Drug Therapy, Combination; High-Throughput Screening Assays; Internet; Malaria, Falciparum; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinine | 2013 |
Plasmodium falciparum Polymorphisms associated with ex vivo drug susceptibility and clinical effectiveness of artemisinin-based combination therapies in Benin.
Topics: Amodiaquine; Antimalarials; Artemisinins; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Inhibitory Concentration 50; Lumefantrine; Male; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Quinine; Sulfadoxine | 2014 |
Evidence for pyronaridine as a highly effective partner drug for treatment of artemisinin-resistant malaria in a rodent model.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Resistance; Female; Flow Cytometry; Malaria, Falciparum; Mefloquine; Mice; Naphthyridines | 2014 |
The survival times of malaria-infected mice are prolonged more by several new two-carbon-linked artemisinin-derived dimer carbamates than by the trioxane antimalarial drug artemether.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Carbamates; Carbon; Crystallography, X-Ray; Dimerization; Drug Therapy, Combination; Malaria; Mefloquine; Mice; Molecular Conformation; Plasmodium berghei; Structure-Activity Relationship; Survival Analysis | 2014 |
Complex polymorphisms in the Plasmodium falciparum multidrug resistance protein 2 gene and its contribution to antimalarial response.
Topics: Amino Acid Sequence; Antimalarials; Artemisinins; Biological Transport; Chloroquine; Chromosomes; Drug Resistance, Multiple; Erythrocytes; Humans; INDEL Mutation; Malaria, Falciparum; Mefloquine; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Single Nucleotide; Quinolines; Thailand | 2014 |
Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Cambodia; Chloroquine; Drug Resistance; Female; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Male; Mefloquine; Membrane Transport Proteins; Middle Aged; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Young Adult | 2015 |
Assessment of the Worldwide Antimalarial Resistance Network Standardized Procedure for In Vitro Malaria Drug Sensitivity Testing Using SYBR Green Assay for Field Samples with Various Initial Parasitemia Levels.
Topics: Antimalarials; Artemisinins; Atovaquone; Benzothiazoles; Biological Assay; Chloroquine; Diamines; DNA, Protozoan; Drug Resistance; Erythrocytes; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Organic Chemicals; Parasitemia; Plasmodium falciparum; Public Health Surveillance; Quinolines; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Repetitive live sporozoites inoculation under arteether chemoprophylaxis confers protection against subsequent sporozoite challenge in rodent malaria model.
Topics: Animals; Antimalarials; Artemisinins; Chemoprevention; Chloroquine; Female; Immunization; Malaria; Mefloquine; Mice; Parasite Load; Plasmodium yoelii; Primaquine; Sporozoites; Vaccination | 2016 |
Back on TRAC: New trial launched in bid to outpace multidrug-resistant malaria.
Topics: Antimalarials; Artemisinins; Asia, Southeastern; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; India; Malaria; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Quinolines | 2016 |
Highly active ozonides selected against drug resistant malaria.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Disease Models, Animal; Female; Humans; Malaria, Falciparum; Mefloquine; Mice; Parasitemia; Plasmodium falciparum | 2016 |
Partner-Drug Resistance and Population Substructuring of Artemisinin-Resistant Plasmodium falciparum in Cambodia.
Topics: Adult; Antipruritics; Artemisinins; Cambodia; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Phylogeny; Plasmodium falciparum; Protozoan Proteins; Quinolines; Treatment Failure | 2017 |
Cellular mechanisms of action and resistance of Plasmodium falciparum to artemisinin.
Topics: Antimalarials; Antioxidants; Artemisinins; Artesunate; Drug Resistance; Hemeproteins; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Polymorphism, Genetic; Thailand | 2017 |
Investigating the Efficacy of Triple Artemisinin-Based Combination Therapies for Treating Plasmodium falciparum Malaria Patients Using Mathematical Modeling.
Topics: Antimalarials; Artemisinins; Asia, Southeastern; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Models, Theoretical; Plasmodium falciparum; Quinolines | 2018 |
Plasmodium falciparum Clearance Is Pitting-Dependent With Artemisinin-Based Drugs but Pitting-Independent With Atovaquone-Proguanil or Mefloquine.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Atovaquone; Child; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Proguanil; Young Adult | 2019 |
Improving Methods for Analyzing Antimalarial Drug Efficacy Trials: Molecular Correction Based on Length-Polymorphic Markers
Topics: Algorithms; Antigens, Protozoan; Antimalarials; Artemisinins; Biomarkers; Clinical Trials as Topic; Gene Expression; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Merozoite Surface Protein 1; Models, Statistical; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Restriction Fragment Length; Protozoan Proteins; Quinolines; Time Factors; Treatment Outcome | 2019 |
Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in Northern Uganda.
Topics: Amodiaquine; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Lumefantrine; Mefloquine; Plasmodium falciparum; Quinine; Uganda | 2021 |
Prevalence and characterization of piperaquine, mefloquine and artemisinin derivatives triple-resistant Plasmodium falciparum in Cambodia.
Topics: Antimalarials; Artemisinins; Artesunate; Cambodia; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Prevalence; Quinolines | 2023 |
Molecular surveillance of Plasmodium falciparum drug-resistance markers in Vietnam using multiplex amplicon sequencing (2000-2016).
Topics: Artemisinins; Genotype; Mefloquine; Plasmodium falciparum; Vietnam | 2023 |